Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.
Not Applicable
- Conditions
- Dry eye
- Registration Number
- JPRN-UMIN000024064
- Lead Sponsor
- Santen Pharmaceutical Co., Ltd.
- Brief Summary
Refer to paper
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
Patients have administration of eye drops for dry eye or steroid eye drops 14 days before start day of this study. Patient with an infection eye disease. Patient has a complication of an eye disease except dry eye. This complication is feared to discourage from evaluation of this study. Patients with allergy to the ingredients used in the present study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method